All In Biotech

Drug Trial Radar · NCT04930432

Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors

A Phase I/II Study of MCLA-129, a Human Anti-EGFR and Anti-c-Met Bispecific Antibody, in Patients With Advanced NSCLC and Other Solid Tumors, Evaluating Safety, Pharmacokinetic Characteristics and Antitumor Activity

Last checked: Nov 19, 2026Latest source record: Feb 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

400

Planned (sponsor's estimate)

Start

Sep 24, 2021

Primary completion

Apr 30, 2028

Study completion Dec 30, 2028

Sponsor

Sponsor type
Industry
First posted
Jun 18, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, open-label, Phase I/II clinical study of MCLA-129 as monotherapy in patients with advanced solid tumors to evaluate the safety, pharmacokinetic characteristics and antitumor activity of MCLA-129.

Conditions

  • Solid Tumor
  • Non-Small Cell Lung Cancer
  • Head and Neck Cancer
  • Colorectal Cancer

Interventions

  • MCLA-129Drug

    MCLA-129 will be administered by intravenous infusion on the 28-day treatment cycle.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Dose-Limiting Toxicity (DLT) in Part 1Time frame: First 28 days of treatment
  2. Maximum Tolerated Dose (MTD) in Part 1Time frame: First 28 days of treatment
  3. Overall Response Rate (ORR) in Part 2Time frame: From date of first treatment every 6 weeks until disease progression, death or withdrawal, whichever came first, approximately 2 years
  4. Treatment-Emergent Adverse Event (TEAE) in Part 1 and 2Time frame: Until 30 days after the last dosing

Locations

87 sites in 1 country. Site status is shown where the registry gives one.

  • Affiliated Hospital of Hebei University

    Baoding, China · Recruiting

  • Beijing Cancer Hospital

    Beijing, China · Recruiting

  • Beijing Friendship Hospital, Capital Medical University

    Beijing, China · Recruiting

  • Beijing Tongren Hospital

    Beijing, China · Recruiting

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    Beijing, China · Recruiting

  • Peking University International Hospital

    Beijing, China · Recruiting

  • The Fifth Medical Center of PLA Ceneral Hospital

    Beijing, China · Recruiting

  • The First Affiliated Hospital of Bengbu Medical College

    Bengbu, China · Recruiting

  • The First Affiliated Hospital of Bengbu Medical University

    Bengbu, China · Recruiting

  • Cangzhou Hospital of Integrated TCM-WM·Hebei

    Cangzhou, China · Recruiting

  • China-Japan Union Hospitai Of Jilin University

    Ch’ang-ch’un, China · Recruiting

  • Ji Lin Cancer Hospital

    Changchun, China · Recruiting

  • Hunan Cancer Hospital

    Changsha, China · Recruiting

  • The Second Xiangya Hospital of Central South University

    Changsha, China · Recruiting

  • Xiangya Hospital of Central South University

    Changsha, China · Recruiting

  • Sichuan Cancer Hospital

    Chengdu, China · Recruiting

  • West China Hospital, Sichuan University

    Chengdu, China · Recruiting

  • Chifeng Municipal Hospital

    Chifeng, China · Recruiting

  • Army Medical Center of PLA

    Chongqing, China · Recruiting

  • Chongqing University Cancer Hospital

    Chongqing, China · Recruiting

  • The First Affiliated Hospital of Dalian Medical University

    Dalian, China · Recruiting

  • Fujian Cancer Hospital

    Fuzhou, China · Recruiting

  • Fuzhou Pulmonary Hospital of Fujian

    Fuzhou, China · Recruiting

  • The 900 Hospital of the Joint Service Support Force of the People's Liberation Army of China

    Fuzhou, China · Recruiting

  • First Affiliated Hospital Of Gannan Medical University

    Ganzhou, China · Recruiting

  • Guangdong Province Traditional Chinese Medical Hospital

    Guangzhou, China · Recruiting

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University

    Guangzhou, China · Recruiting

  • The Frist Affiliated Hospital of Guangzhou Medical College

    Guangzhou, China · Recruiting

  • The Sixth Affiliated Hospital, Sun Yat-sen University

    Guangzhou, China · Recruiting

  • Cancer Hospital affiliated to Harbin Medical University

    Ha’erbin, China · Recruiting

  • Harbin Medical University cancer hospital

    Ha’erbin, China · Recruiting

  • Cancer Hospital of The University of Chinese Academy of Sciences

    Hangzhou, China · Recruiting

  • The First Affiliated Hospital, Zhejiang University School of Medicine

    Hangzhou, China · Recruiting

  • The Second Affiliated Hospital Zhejiang University School of Medicine

    Hangzhou, China · Recruiting

  • Zhejiang Cancer Hospital

    Hangzhou, China · Recruiting

  • Hanzhong Central Hospital

    Hanzhong, China · Recruiting

  • Harbin Medical University Cancer Hospital

    Harbin, China · Recruiting

  • The Second Hospital of Anhui Medical University

    Hefei, China · Recruiting

  • Henan Cancer Hospital (Affiliated Cancer Hospital of Zhengzhou University)

    Henan, China · Recruiting

  • Inner Mongolia People's Hospital

    Hohhot, China · Recruiting

Showing 40 of 87 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.